AhR and Arnt differentially regulate NF-κB signaling and chemokine responses in human bronchial epithelial cells

Cell Communication and Signaling

Volumn 12, Issue 1, 2014, Pages

  Øvrevik, Johan ^a   Låg, Marit ^a   Lecureur, Valerie ^b,c   Gilot, David ^c,d   Lagadic Gossmann, Dominique ^b,c   Refsnes, Magne ^a   Schwarze, Per E ^a   Skuland, Tonje ^a   Becher, Rune ^a   Holme, Jørn A ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITÉ DE RENNES 1   (France)

^c FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^d UNIVERSITÉ DE RENNES 1   (France)

Author keywords

AhR nuclear translocator; Aryl hydrocarbon receptor; Inflammation; interleukin 8; Lung epithelial cells; Nuclear factor NF B; p65; RANTES; RelB

Indexed keywords

ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; POLYINOSINIC POLYCYTIDYLIC ACID; RANTES; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA; 1-AMINOPYRENE; 1-NITROPYRENE; AIR POLLUTANT; ALPHA-NAPHTHOFLAVONE; ARNT PROTEIN, HUMAN; BENZOFLAVONE DERIVATIVE; CCL5 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; PYRENE DERIVATIVE; SERINE;

ARTICLE; BRONCHIAL EPITHELIAL CELL; BRONCHUS MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; AIR POLLUTANT; ANTAGONISTS AND INHIBITORS; BRONCHUS; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHARMACOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

AIR POLLUTANTS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BENZOFLAVONES; BRONCHI; CELL LINE, TUMOR; CHEMOKINE CCL5; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-8; NF-KAPPA B; PHOSPHORYLATION; POLY I-C; PYRENES; RECEPTORS, ARYL HYDROCARBON; SERINE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906932819     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/s12964-014-0048-8     Document Type: Article

References (63)

1. Aryl hydrocarbon receptor-mediated signal transduction. JC Rowlands, JA Gustafsson, Crit Rev Toxicol 1997 27 109 134 10.3109/10408449709021615 9099515
2. The cardiopulmonary continuum systemic inflammation as 'common soil' of heart and lung disease. C Ukena, F Mahfoud, M Kindermann, I Kindermann, R Bals, AA Voors, DJ van Veldhuisen, M Bohm, Int J Cardiol 2010 145 172 176 10.1016/j.ijcard.2010.04.082 20570377
3. Inflammation as "common soil" of the multifactorial diseases. R Scrivo, M Vasile, I Bartosiewicz, G Valesini, Autoimmun Rev 2011 10 369 374 10.1016/j.autrev.2010.12.006 21195808
4. Inhalation of environmental stressors & chronic inflammation: autoimmunity and neurodegeneration. SE Gomez-Mejiba, Z Zhai, H Akram, QN Pye, K Hensley, BT Kurien, RH Scofield, DC Ramirez, Mutat Res 2009 674 62 72 10.1016/j.mrgentox.2008.09.016 18977456
5. Could dirty air cause diabetes? A Bhatnagar, Circulation 2009 119 492 494 10.1161/CIRCULATIONAHA.108.831404 19188518
6. MicroRNAs in inflammation and response to injuries induced by environmental pollution. E Sonkoly, A Pivarcsi, Mutat Res 2011 717 46 53 10.1016/j.mrfmmm.2011.02.002 21329708
7. Ah receptor and NF-kappaB interactions: mechanisms and physiological implications. Y Tian, AB Rabson, MA Gallo, Chem Biol Interact 2002 141 97 115 10.1016/S0009-2797(02)00068-6 12213387
8. A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family. CF Vogel, F Matsumura, Biochem Pharmacol 2009 77 734 745 10.1016/j.bcp.2008.09.036 18955032
9. Aryl hydrocarbon receptor in association with RelA modulates IL-6 expression in non-smoking lung cancer. PH Chen, H Chang, JT Chang, P Lin, Oncogene 2012 31 2555 2565 10.1038/onc.2011.438 21996739
10. A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. S Kobayashi, H Okamoto, T Iwamoto, Y Toyama, T Tomatsu, H Yamanaka, S Momohara, Rheumatology (Oxford) 2008 47 1317 1322 10.1093/rheumatology/ken259
11. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. CF Vogel, E Sciullo, W Li, P Wong, G Lazennec, F Matsumura, Mol Endocrinol 2007 21 2941 2955 10.1210/me.2007-0211 17823304
12. Interaction of aryl hydrocarbon receptor and NF-kappaB subunit RelB in breast cancer is associated with interleukin-8 overexpression. CF Vogel, W Li, D Wu, JK Miller, C Sweeney, G Lazennec, Y Fujisawa, F Matsumura, Arch Biochem Biophys 2011 512 78 86 10.1016/j.abb.2011.05.011 21640702
13. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. DW Kim, L Gazourian, SA Quadri, R Romieu-Mourez, DH Sherr, GE Sonenshein, Oncogene 2000 19 5498 5506 10.1038/sj.onc.1203945 11114727
14. Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. M Tauchi, A Hida, T Negishi, F Katsuoka, S Noda, J Mimura, T Hosoya, A Yanaka, H Aburatani, Y Fujii-Kuriyama, H Motohashi, M Yamamoto, Mol Cell Biol 2005 25 9360 9368 10.1128/MCB.25.21.9360-9368.2005 16227587
15. Interleukin-8 induction by the environmental contaminant benzo (a) pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation. N Podechard, V Lecureur, E Le Ferrec, I Guenon, L Sparfel, D Gilot, JR Gordon, V Lagente, O Fardel, Toxicol Lett 2008 177 130 137 10.1016/j.toxlet.2008.01.006 18289803
16. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. TH Thatcher, SB Maggirwar, CJ Baglole, HF Lakatos, TA Gasiewicz, RP Phipps, Am J Pathol 2007 170 855 864 10.2353/ajpath.2007.060391 17322371
17. Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis. CA Beamer, BP Seaver, DM Shepherd, Toxicol Sci 2012 126 554 568 10.1093/toxsci/kfs024 22273745
18. Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. H Sekine, J Mimura, M Oshima, H Okawa, J Kanno, K Igarashi, FJ Gonzalez, T Ikuta, K Kawajiri, Y Fujii-Kuriyama, Mol Cell Biol 2009 29 6391 6400 10.1128/MCB.00337-09 19822660
19. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. A Kimura, T Naka, T Nakahama, I Chinen, K Masuda, K Nohara, Y Fujii-Kuriyama, T Kishimoto, J Exp Med 2009 206 2027 2035 10.1084/jem.20090560 19703987
20. The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. CJ Baglole, SB Maggirwar, TA Gasiewicz, TH Thatcher, RP Phipps, PJ Sime, J Biol Chem 2008 283 28944 28957 10.1074/jbc.M800685200 18697742
21. A role of the aryl hydrocarbon receptor in attenuation of colitis. K Furumatsu, S Nishiumi, Y Kawano, M Ooi, T Yoshie, Y Shiomi, H Kutsumi, H Ashida, Y Fujii-Kuriyama, T Azuma, M Yoshida, Dig Dis Sci 2011 56 2532 2544 10.1007/s10620-011-1643-9 21374063
22. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. Y Tian, S Ke, MS Denison, AB Rabson, MA Gallo, J Biol Chem 1999 274 510 515 10.1074/jbc.274.1.510 9867872
23. Cytokine and chemokine expression patterns in lung epithelial cells exposed to components characteristic of particulate air pollution. J Øvrevik, M Låg, JA Holme, PE Schwarze, M Refsnes, Toxicology 2009 259 46 53 10.1016/j.tox.2009.01.028 19428942
24. Differential effects of nitro-PAHs and amino-PAHs on cytokine and chemokine responses in human bronchial epithelial BEAS-2B cells. J Øvrevik, VM Arlt, E Oya, E Nagy, S Mollerup, DH Phillips, M Låg, JA Holme, Toxicol Appl Pharmacol 2010 242 270 280 10.1016/j.taap.2009.10.017 19879285
25. The effects and comparative differences of neutrophil specific chemokines on neutrophil chemotaxis of the neonate. SE Fox, W Lu, A Maheshwari, RD Christensen, DA Calhoun, Cytokine 2005 29 135 140 10.1016/j.cyto.2004.10.007 15613281
26. Chemokines in health and disease. V Gangur, NP Birmingham, S Thanesvorakul, Vet Immunol Immunopathol 2002 86 127 136 10.1016/S0165-2427(02)00018-1 12007879
27. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. LR Bisset, P Schmid-Grendelmeier, Curr Opin Pulm Med 2005 11 35 42 10.1097/01.mcp.0000144502.50149.e0 15591886
28. Interleukin-8 and human cancer biology. K Xie, Cytokine Growth Factor Rev 2001 12 375 391 10.1016/S1359-6101(01)00016-8 11544106
29. Prospects for cytokine and chemokine biotherapy. JJ Oppenheim, WJ Murphy, O Chertox, V Schirrmacher, JM Wang, Clin Cancer Res 1997 3 2682 2686 10068274
30. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. A Yuan, PC Yang, CJ Yu, WJ Chen, FY Lin, SH Kuo, KT Luh, Am J Respir Crit Care Med 2000 162 1957 1963 11069840
31. RANTES expression is a predictor of survival in stage I lung adenocarcinoma. CJ Moran, DA Arenberg, CC Huang, TJ Giordano, DG Thomas, DE Misek, G Chen, MD Iannettoni, MB Orringer, S Hanash, DG Beer, Clin Cancer Res 2002 8 3803 3812 12473593
32. RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. JJ Mule, M Custer, B Averbook, JC Yang, JS Weber, DV Goeddel, SA Rosenberg, TJ Schall, Hum Gene Ther 1996 7 1545 1553 10.1089/hum.1996.7.13-1545 8864755
33. Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors. M Kutubuddin, HJ Federoff, PM Challita-Eid, M Halterman, B Day, M Atkinson, V Planelles, JD Rosenblatt, Blood 1999 93 643 654 9885227
34. Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells. C Henriquet, C Gougat, A Combes, G Lazennec, M Mathieu, Lung Cancer 2007 56 167 174 10.1016/j.lungcan.2006.12.003 17207890
35. Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. QM Nhu, K Shirey, JR Teijaro, DL Farber, S Netzel-Arnett, TM Antalis, A Fasano, SN Vogel, Mucosal Immunol 2010 3 29 39 10.1038/mi.2009.120 19865078
36. TACE/TGF-alpha/EGFR regulates CXCL8 in bronchial epithelial cells exposed to particulate matter components. J Øvrevik, M Refsnes, AI Totlandsdal, JA Holme, PE Schwarze, M Låg, Eur Respir J 2011 38 1189 1199 10.1183/09031936.00171110 21540303
37. Differential chemokine induction by 1-nitropyrene and 1-aminopyrene in bronchial epithelial cells: Importance of the TACE/TGF-alpha/EGFR-pathway. J Øvrevik, JA Holme, M Låg, PE Schwarze, M Refsnes, Environ Toxicol Pharmacol 2013 35 235 239 10.1016/j.etap.2012.12.011 23348104
38. Mechanisms of chemokine responses by polycyclic aromatic hydrocarbons in bronchial epithelial cells: sensitization through toll-like receptor-3 priming. J Øvrevik, M Refsnes, JA Holme, PE Schwarze, M Låg, Toxicol Lett 2013 219 125 132 10.1016/j.toxlet.2013.02.014 23458896
39. Calcium signaling and beta2-adrenergic receptors regulate 1-nitropyrene induced CXCL8 responses in BEAS-2B cells. A Mayati, FE Le, JA Holme, O Fardel, D Lagadic-Gossmann, J Øvrevik, Toxicol in Vitro 2014 28 1153 1157 10.1016/j.tiv.2014.05.012 24904980
40. Multiple control of interleukin-8 gene expression. E Hoffmann, O Dittrich-Breiholz, H Holtmann, M Kracht, J Leukoc Biol 2002 72 847 855 12429706
41. Effects of nitrated-polycyclic aromatic hydrocarbons and diesel exhaust particle extracts on cell signalling related to apoptosis: possible implications for their mutagenic and carcinogenic effects. NE Landvik, M Gorria, VM Arlt, N Asare, A Solhaug, D Lagadic-Gossmann, JA Holme, Toxicology 2007 231 159 174 10.1016/j.tox.2006.12.009 17240030
42. Signalling pathways involved in 1-nitropyrene (1-NP)-induced and 3-nitrofluoranthene (3-NF)-induced cell death in Hepa1c1c7 cells. N Asare, X Tekpli, M Rissel, A Solhaug, N Landvik, V Lecureur, N Podechard, G Brunborg, M Låg, D Lagadic-Gossmann, JA Holme, Mutagenesis 2009 24 481 493 10.1093/mutage/gep032 19703935
43. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. S Doyle, S Vaidya, R O'Connell, H Dadgostar, P Dempsey, T Wu, Immunity 2002 17 251 263 10.1016/S1074-7613(02)00390-4 12354379
44. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells. S Matsukura, F Kokubu, M Kurokawa, M Kawaguchi, K Ieki, H Kuga, M Odaka, S Suzuki, S Watanabe, H Takeuchi, T Kasama, M Adachi, Clin Exp Allergy 2006 36 1049 1062 10.1111/j.1365-2222.2006.02530.x 16911361
45. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa} B at serine 536 is mediated by multiple protein kinases including I {kappa} B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. H Buss, A Dorrie, ML Schmitz, E Hoffmann, K Resch, M Kracht, J Biol Chem 2004 279 55633 55643 10.1074/jbc.M409825200 15489227
46. Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor. B Schmeck, J Zahlten, K Moog, LV Van, S Huber, AC Hocke, B Opitz, E Hoffmann, M Kracht, J Zerrahn, S Hammerschmidt, S Rosseau, N Suttorp, S Hippenstiel, J Biol Chem 2004 279 53241 53247 10.1074/jbc.M313702200 15485852
47. Transcription of the RelB gene is regulated by NF-kappaB. GD Bren, NJ Solan, H Miyoshi, KN Pennington, LJ Pobst, CV Paya, Oncogene 2001 20 7722 7733 10.1038/sj.onc.1204868 11753650
48. RelB forms transcriptionally inactive complexes with RelA/p65. R Marienfeld, MJ May, I Berberich, E Serfling, S Ghosh, M Neumann, J Biol Chem 2003 278 19852 19860 10.1074/jbc.M301945200 12657634
49. The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kappaB-dependent transcription. CW Wright, CS Duckett, Science 2009 323 251 255 10.1126/science.1162818 19131627
50. Non-canonical NF-kappaB signaling pathway. SC Sun, Cell Res 2011 21 71 85 10.1038/cr.2010.177 21173796
51. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. H Sakurai, H Chiba, H Miyoshi, T Sugita, W Toriumi, J Biol Chem 1999 274 30353 30356 10.1074/jbc.274.43.30353 10521409
52. The Ah Receptor Recruits IKKalpha to Its Target Binding Motifs to Phosphorylate Serine-10 in Histone H3 Required for Transcriptional Activation. H Kurita, M Schnekenburger, JL Ovesen, Y Xia, A Puga, Toxicol Sci 2014 139 121 132 10.1093/toxsci/kfu027 24519526
53. Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-kappaB. CF Vogel, EM Khan, PS Leung, ME Gershwin, WL Chang, D Wu, T Haarmann-Stemmann, A Hoffmann, MS Denison, J Biol Chem 2014 289 1866 1875 10.1074/jbc.M113.505578 24302727
54. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. J Suh, YJ Jeon, HM Kim, JS Kang, NE Kaminski, KH Yang, Toxicol Appl Pharmacol 2002 181 116 123 10.1006/taap.2002.9403 12051995
55. AhR deficiency impairs expression of LPS-induced inflammatory genes in mice. D Wu, W Li, P Lok, F Matsumura, CF Vogel, Biochem Biophys Res Commun 2011 410 358 363 10.1016/j.bbrc.2011.06.018 21683686
56. Xenobiotic metabolism and disposition in human lung cell models: comparison with in vivo expression profiles. E Courcot, J Leclerc, JJ Lafitte, E Mensier, S Jaillard, P Gosset, P Shirali, N Pottier, F Broly, JM Lo-Guidice, Drug Metab Dispos 2012 40 1953 1965 10.1124/dmd.112.046896 22798553
57. Aryl hydrocarbon receptor signaling regulates NF-kappaB RelB activation during dendritic-cell differentiation. CF Vogel, D Wu, SR Goth, J Baek, A Lollies, R Domhardt, A Grindel, IN Pessah, Immunol Cell Biol 2013 91 568 575 10.1038/icb.2013.43 23999131
58. Differential effects of the particle core and organic extract of diesel exhaust particles. AI Totlandsdal, JI Herseth, AK Bolling, A Kubatova, A Braun, RE Cochran, M Refsnes, J Øvrevik, M Låg, Toxicol Lett 2012 208 262 268 10.1016/j.toxlet.2011.10.025 22100492
59. Interindividual difference in expression of human Ah receptor and related P450 genes. S Hayashi, J Watanabe, K Nakachi, H Eguchi, O Gotoh, K Kawajiri, Carcinogenesis 1994 15 801 806 10.1093/carcin/15.5.801 7515333
60. RNA expressions of AHR, ARNT and CYP1B1 are influenced by AHR Arg554Lys polymorphism. S Helmig, JU Seelinger, J Dohrel, J Schneider, Mol Genet Metab 2011 104 180 184 10.1016/j.ymgme.2011.06.009 21742528
61. Mechanisms of silica-induced IL-8 release from A549 cells: initial kinase-activation does not require EGFR activation or particle uptake. J Øvrevik, M Refsnes, E Namork, R Becher, D Sandnes, PE Schwarze, M Låg, Toxicology 2006 227 105 116 10.1016/j.tox.2006.07.029 16963169
62. Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification. B Raymond, E Batsche, F Boutillon, YZ Wu, D Leduc, V Balloy, E Raoust, C Muchardt, PL Goossens, L Touqui, PLoS Pathog 2009 5 1000359 10.1371/journal.ppat.1000359 19343203
63. Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling. C Dai, X Wen, W He, Y Liu, J Biol Chem 2011 286 7052 7059 10.1074/jbc.M110.174821 21189258